Hypofractionated Radiation Therapy for Prostate Cancer

 

As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments.  Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations […]

 

Learn More

 

 

New Clinical Trials for Prostate Cancer Now Available

 

Two clinical trials opened for enrollment in late 2019 at UofL Health – James Graham Brown Cancer Center for eligible men with prostate cancer. “Since the Brown Cancer Center has these clinical trials available, we can offer our prostate cancer patients the latest cancer treatments,” Scott Silva, M.D., Ph.D. , radiation oncologist, said. Men with favorable intermediate risk […]

 

Learn More

 

 

Prostate Cancer Treatment and Sexual Function

 

When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration.  While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them.  That choice is often based on treatment outcomes and side effects, and […]

 

Learn More

 

 

Studies Show CyberKnife Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions

 

Accuray Incorporated, developer and manufacturer of the CyberKnife® System, announced that published data from two multicenter studies using differing protocols provide consistent results and reinforce the use of the CyberKnife system for the effective management of low-and intermediate-risk prostate cancer.  The studies are the largest conducted to date evaluating stereotactic body radiation therapy (SBRT) in […]

 

Learn More

 

 

American Urological Association, American Society for Radiation Oncology, and the Society of Urologic Oncology Release Joint Prostate Cancer Guidelines

 

Last week, the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) released collaborative clinical guidelines for managing localized prostate cancer which offers a framework for shared decision-making between physicians and patients.  Through this collaboration, the committee provided guidance on active surveillance and on which treatments […]

 

Learn More

 

 

The U.S. Preventive Services Task Force Updates Screening Guidelines for Prostate Cancer

 

The U.S. Preventive Services Task Force (USPSTF) recently updated their prostate screening recommendations. On April 11, 2017, the USPSTF issued an updated draft recommendation on screening for prostate cancer.  The updated recommendation changes the grade for PSA-based screening from “D” to “C” for men 55 – 69 years of age.  As a result, the USPSTF […]

 

Learn More

 

 

Your Prostate, Your Cancer, Your Choice with Dr. Woo

 

 

Learn More

 

 

Scientists Find New Gene Tool for Predicting Course of Prostate Cancer

 

A recent research paper in Oncotarget, a weekly peer-reviewed open access medical journal covering research on all aspects of oncology, reported that researchers from UR Medicine’s Wilmot Cancer Institute and Roswell Park Cancer Institute have discovered a possible new tool for predicting whether prostate cancer will reoccur following surgery based on the expression patterns of […]

 

Learn More

 

 

Managing Cancer as a Chronic Illness

 

June is National Cancer Survivor Month.  It is a month dedicated to celebrating and recognizing those who have survived cancer, an inspiration for those recently diagnosed, a gathering of support for families, and an outreach to the community.   According to the Centers for Disease Control and Prevention (CDC), the leading national public health institute […]

 

Learn More

 

 

Prostate Cancer: Take Time to Decide infographic

 

 

Learn More